New hope for kids with tough cancers: First-of-its-Kind cell therapy trial
NCT ID NCT06612645
Summary
This early-stage study is testing a new type of personalized immune cell therapy called CMD03 in children and young adults whose solid tumors have come back or haven't responded to standard treatments. Doctors take a patient's own immune cells, modify them in a lab to better target cancer, and infuse them back. The main goals are to see if this treatment is safe and to look for early signs that it can help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC CANCERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
King Chulalongkorn Memorial Hospital
RECRUITINGBangkok, Pathumwan, 10330, Thailand
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.